Novo Nordisk Pharmaceutical Products

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Bagsværd, Denmark. The company is primarily recognized for its leadership in diabetes care, having pioneered the production of insulin, as well as its significant contributions to obesity management, rare blood disorders, and endocrine disorders.

The brand's manufacturing footprint is truly global, with state-of-the-art production facilities located in Denmark, the United States, France, Brazil, China, and several other countries. This international network ensures that their life-saving medications reach millions of patients worldwide. Novo Nordisk is uniquely governed by the Novo Nordisk Foundation, which holds the majority of voting rights through its holding company, Novo Holdings A/S, ensuring a long-term focus on research and sustainability.